375 related articles for article (PubMed ID: 15547183)
21. ["Mirror, mirror on the wall which is the best proton pump inhibitor of all?"].
Labenz J; Petersen KU; Rösch W; Koelz HR
Z Gastroenterol; 2003 Nov; 41(11):1123. PubMed ID: 14648385
[No Abstract] [Full Text] [Related]
22. Lack of pantoprazole drug interactions in man: an updated review.
Steinijans VW; Huber R; Hartmann M; Zech K; Bliesath H; Wurst W; Radtke HW
Int J Clin Pharmacol Ther; 1996 Jun; 34(6):243-62. PubMed ID: 8793611
[TBL] [Abstract][Full Text] [Related]
23. Lack of pantoprazole drug interactions in man.
Steinijans VW; Huber R; Hartmann M; Zech K; Bliesath H; Wurst W; Radtke HW
Int J Clin Pharmacol Ther; 1994 Aug; 32(8):385-99. PubMed ID: 7981922
[TBL] [Abstract][Full Text] [Related]
24. Proton pump inhibitors enhance the effects of cytotoxic agents in chemoresistant epithelial ovarian carcinoma.
Lee YY; Jeon HK; Hong JE; Cho YJ; Ryu JY; Choi JJ; Lee SH; Yoon G; Kim WY; Do IG; Kim MK; Kim TJ; Choi CH; Lee JW; Bae DS; Kim BG
Oncotarget; 2015 Oct; 6(33):35040-50. PubMed ID: 26418900
[TBL] [Abstract][Full Text] [Related]
25. Intragastric acidity after switching from 5-day treatment with intravenous pantoprazole 40 mg/d to 5-day treatment with oral esomeprazole 40 mg/d or pantoprazole 40 mg/d: an open-label crossover study in healthy adult volunteers.
Miner PB; Tutuian R; Castell DO; Liu S; Sostek MB
Clin Ther; 2006 May; 28(5):725-33. PubMed ID: 16861094
[TBL] [Abstract][Full Text] [Related]
26. [Recent topics on important drugs for H. pylori eradication: Pantoprazole sodium].
Okazaki K; Mori S; Tahashi K
Nihon Rinsho; 2005 Nov; 63 Suppl 11():354-60. PubMed ID: 16363559
[No Abstract] [Full Text] [Related]
27. Effects on 24-hour intragastric pH: a comparison of lansoprazole administered nasogastrically in apple juice and pantoprazole administered intravenously.
Freston J; Chiu YL; Pan WJ; Lukasik N; Täubel J
Am J Gastroenterol; 2001 Jul; 96(7):2058-65. PubMed ID: 11467632
[TBL] [Abstract][Full Text] [Related]
28. Pharmacodynamic effects of 3-day intravenous treatment with pantoprazole or ranitidine after 10 days of oral ranitidine.
Ley LM; Becker A; Lühmann R; Sander P; Lücker PW
Methods Find Exp Clin Pharmacol; 2005; 27(1):25-9. PubMed ID: 15834456
[TBL] [Abstract][Full Text] [Related]
29. Effect of pantoprazole versus other proton pump inhibitors on 24-hour intragastric pH and basal acid output in Zollinger-Ellison syndrome.
Ramdani A; Mignon M; Samoyeau R
Gastroenterol Clin Biol; 2002 Apr; 26(4):355-9. PubMed ID: 12070410
[TBL] [Abstract][Full Text] [Related]
30. Intragastric acid control in non-steroidal anti-inflammatory drug users: comparison of esomeprazole, lansoprazole and pantoprazole.
Goldstein JL; Miner PB; Schlesinger PK; Liu S; Silberg DG
Aliment Pharmacol Ther; 2006 Apr; 23(8):1189-96. PubMed ID: 16611280
[TBL] [Abstract][Full Text] [Related]
31. [Proton pump inhibitors: Pantoprazole].
Takeuchi K; Hase S
Nihon Rinsho; 2002 Feb; 60 Suppl 2():655-60. PubMed ID: 11979865
[No Abstract] [Full Text] [Related]
32. Lack of pantoprazole drug interactions in man: an updated review.
Steinijans VW; Huber R; Hartmann M; Zech K; Bliesath H; Wurst W; Radtke HW
Int J Clin Pharmacol Ther; 1996 May; 34(1 Suppl):S31-50. PubMed ID: 8793602
[TBL] [Abstract][Full Text] [Related]
33. pH-dependent antitumor activity of proton pump inhibitors against human melanoma is mediated by inhibition of tumor acidity.
De Milito A; Canese R; Marino ML; Borghi M; Iero M; Villa A; Venturi G; Lozupone F; Iessi E; Logozzi M; Della Mina P; Santinami M; Rodolfo M; Podo F; Rivoltini L; Fais S
Int J Cancer; 2010 Jul; 127(1):207-19. PubMed ID: 19876915
[TBL] [Abstract][Full Text] [Related]
34. Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers.
Pegram M; Hsu S; Lewis G; Pietras R; Beryt M; Sliwkowski M; Coombs D; Baly D; Kabbinavar F; Slamon D
Oncogene; 1999 Apr; 18(13):2241-51. PubMed ID: 10327070
[TBL] [Abstract][Full Text] [Related]
35. Pantoprazole: a novel H+/K(+)-ATPase inhibitor with an improved pH stability.
Beil W; Staar U; Sewing KF
Eur J Pharmacol; 1992 Aug; 218(2-3):265-71. PubMed ID: 1330598
[TBL] [Abstract][Full Text] [Related]
36. Current status of acid pump antagonists (reversible PPIs).
Wurst W; Hartmann M
Yale J Biol Med; 1996; 69(3):233-43. PubMed ID: 9165692
[TBL] [Abstract][Full Text] [Related]
37. Intravenous proton pump inhibitors.
Baker DE
Rev Gastroenterol Disord; 2006; 6(1):22-34. PubMed ID: 16520709
[TBL] [Abstract][Full Text] [Related]
38. Establishment and serial quantification of intrahepatic xenografts of human hepatocellular carcinoma in severe combined immunodeficiency mice, and development of therapeutic strategies to overcome multidrug resistance.
Leveille-Webster CR; Arias IA
Clin Cancer Res; 1996 Apr; 2(4):695-706. PubMed ID: 9816220
[TBL] [Abstract][Full Text] [Related]
39. Proton pump inhibitors.
Grover JK; Vats V
Trop Gastroenterol; 1999; 20(1):16-28. PubMed ID: 10464444
[No Abstract] [Full Text] [Related]
40. Attenuating effect of H+K+ATPase inhibitors on airway cough hypersensitivity induced by allergic airway inflammation in guinea-pigs.
Oribe Y; Fujimura M; Kita T; Katayama N; Nishitsuji M; Hara J; Myou S; Nakao S
Clin Exp Allergy; 2005 Mar; 35(3):262-7. PubMed ID: 15784101
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]